Uremic Pruritus Pipeline Insight 2024, Featuring Key Players Cara Therapuetics and Lumosa Therapeutics, and Key Emerging Drugs Cara Therapeutics CR845 and Lumos Therapeutics' LT 5001
April 22, 2024 05:00 ET
|
Research and Markets
Dublin, April 22, 2024 (GLOBE NEWSWIRE) -- The "Uremic Pruritus - Pipeline Insight, 2024" drug pipelines has been added to ResearchAndMarkets.com's offering.The report provides comprehensive...
Pruritus Therapeutics Market Analysis Reveals Promising Growth Opportunities by 2030
January 24, 2024 08:48 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Global Pruritus Therapeutics Market by Therapy (Antihistamines, Calcineurin Inhibitors, Corticosteroids), Disease Indication (Allergic Contact...
Pruritus Therapeutics Market to Reach USD 12.6 Billion by 2032, Poised for Steady 4.1% CAGR
October 17, 2023 07:15 ET
|
MarketResearch.biz
New York, Oct. 17, 2023 (GLOBE NEWSWIRE) -- According to marketresearch.biz, the estimated size of the global pruritus therapeutics market in 2022 was USD 8.5 billion, and it is expected to exhibit...
Global Chronic Pruritus Therapeutics Market Size To Surpass USD 12.1 Billion By 2030 | CAGR of 4.4%
April 17, 2023 06:10 ET
|
SPHERICAL INSIGHTS LLP
New York, United States , April 17, 2023 (GLOBE NEWSWIRE) -- The Global Chronic Pruritus Therapeutics Market Size is To Grow from USD 8.2 Billion in 2021 to USD 12.1 Billion by 2030, at a Compound...